These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 648108)

  • 1. [Therapeutic value of a new oral antidiabetic agent: gliclazide].
    Bernasconi D; Mazzi C
    Clin Ter; 1978 Mar; 84(6):627-35. PubMed ID: 648108
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical trial with a new oral antidiabetic, gliclazid, in general practice (author's transl)].
    Villiger U
    Schweiz Rundsch Med Prax; 1982 Apr; 71(16):699-704. PubMed ID: 7050960
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus].
    Polosa P; Mughini L
    Clin Ter; 1978 Jan; 84(2):135-40. PubMed ID: 648096
    [No Abstract]   [Full Text] [Related]  

  • 4. [Long-term ambulatory treatment of diabetics with gliclazide].
    Parodi FA
    Clin Ter; 1979 Feb; 88(3):281-8. PubMed ID: 376219
    [No Abstract]   [Full Text] [Related]  

  • 5. [Survey of 832 case records of diabetes of adult onset treated by Diamicron. Evolution of metabolism and weight].
    Estivals JP; Giraudet MC; Videau JY
    Journ Annu Diabetol Hotel Dieu; 1978; ():333-40. PubMed ID: 349228
    [No Abstract]   [Full Text] [Related]  

  • 6. [Significance of an oral antidiabetic with vascular action: gliclazide in the asymptomatic diabetes and patent diabetes].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():331-9. PubMed ID: 1011422
    [No Abstract]   [Full Text] [Related]  

  • 7. [[Early results of the treatment of diabetes with a (methyl-4-phenylsulfonyl)-1-[perhydrocyclopenta(C)pyrrolyl-2]-3-urea (gliclazide)].
    Montenero P; Leotta S
    Clin Ter; 1978 Aug; 86(4):319-35. PubMed ID: 737962
    [No Abstract]   [Full Text] [Related]  

  • 8. [Multicentric clinical proof of a new oral antidiabetic glisoxepide (BS 4231). II. Proof of activity in the management of adult onset diabetes].
    Blumenbach L; Kiesselbach NH; Lehnert J
    Arzneimittelforschung; 1974 Mar; 24(0):437-46. PubMed ID: 4603692
    [No Abstract]   [Full Text] [Related]  

  • 9. [Efficacy of gliclazide in short and long-term therapy of older persons with noninsulin-dependent diabetes].
    Djurić DS; Djordjević PB; Micić D; Dragasević M
    Srp Arh Celok Lek; 1981 Nov; 109(11):1503-9. PubMed ID: 7051354
    [No Abstract]   [Full Text] [Related]  

  • 10. Gliclazide (diamicron) in metabolic and vascular treatment of diabetes mellitus.
    Forette B
    East Afr Med J; 1977 Oct; 54(10):579-81. PubMed ID: 608430
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gliclazide in the non-insulin-dependent diabetic patient in geriatrics].
    Frühwald T; Böhmer F
    Wien Med Wochenschr; 1988 Mar; 138(5):102-6. PubMed ID: 3388872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic value of a new original oral antidiabetic with vascular action: gliclazide (SE-1702)].
    Canivet J
    Therapeutique; 1972; 48(7):457-62. PubMed ID: 4640264
    [No Abstract]   [Full Text] [Related]  

  • 13. [A new therapeutic approach to diabetes. Long-term survey].
    Charbonnel B
    Sem Hop Ther; 1977 Nov; 53(9):460-5. PubMed ID: 341321
    [No Abstract]   [Full Text] [Related]  

  • 14. Long term improvement in insulin response with gliclazide treatment.
    Bodansky HJ; Medback S; Cudworth AG; Rees LH; de Silva RS
    Diabete Metab; 1982 Dec; 8(4):319-22. PubMed ID: 6761187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A new antidiabetic agent: glyclazide. A study of glycemic regulation].
    Bour H; Denard Y; Plauchu M; Rathery M; Simonin R; Thervet F; Warembourg H
    Nouv Presse Med; 1974 Feb; 3(5):249-51. PubMed ID: 4819946
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study with glypentide, new sulfonylurea hypoglycemic agent].
    Pou Torelló JM; Vilaclara JM
    Rev Iber Endocrinol; 1974; 21(125):427-30, 433-8, 441-2 passim. PubMed ID: 4608666
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparative evaluation of the hypoglycemic effect of the 2d-generation sulfonylurea preparations maninil and diamicron in diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Levitskaia ZI; Gincherman LE
    Probl Endokrinol (Mosk); 1982; 28(5):9-11. PubMed ID: 6815639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Glipizide: a 2d generation sulfonamide and new antidiabetic].
    Deuil R
    Nouv Presse Med; 1975 Feb; 4(7):500-1. PubMed ID: 1093131
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical trial of a new oral antidiabetic: glypizide].
    Paes E; Gomes FJ; Pinto RE; De Alburquerque MA; Farinha H
    Rev Iber Endocrinol; 1974; 21(125):459-62, 466-6, 469-70 passim. PubMed ID: 4422452
    [No Abstract]   [Full Text] [Related]  

  • 20. [Gliclazide, a new molecule in the treatment of non-insulin-dependent diabetes mellitus].
    Bour H
    Rev Prat; 1980 Feb; 30(9):593-4. PubMed ID: 7361055
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.